Subscribe To
Xphyto announces engagement of consultants for marketing and promotional activities
VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the"Company") announces it has ...
October 8, 2021, 7:00 pm
Educational development clocks 44% revenue decline in q2
Educational Development Corporation (NASDAQ: EDUC) reported a second-quarter FY22 net revenue decline of 44.4% year-on-year, to $32.94 million. T...
October 7, 2021, 1:59 pm
Educational development clocks 44% revenue decline in q2
Educational Development Corporation (NASDAQ: EDUC) reported a second-quarter FY22 net revenue decline of 44.4% year-on-year, to $32.94 million. T...
October 7, 2021, 1:59 pm
Educational development clocks 44% revenue decline in q2
Educational Development Corporation (NASDAQ: EDUC) reported a second-quarter FY22 net revenue decline of 44.4% year-on-year, to $32.94 million. T...
October 7, 2021, 1:59 pm
Psybio therapeutics successfully demonstrates commercial-scale manufacturing feasibility
PsyBio Therapeutics Corp. reported that it has demonstrated the ability to manufacture PsyBio-11040, one of its first promising therapeutic candidates...
October 7, 2021, 9:12 am
Psybio therapeutics successfully demonstrates commercial-scale manufacturing feasibility
PsyBio Therapeutics Corp. reported that it has demonstrated the ability to manufacture PsyBio-11040, one of its first promising therapeutic candidates...
October 7, 2021, 9:12 am
Psybio therapeutics successfully demonstrates commercial-scale manufacturing feasibility
PsyBio Therapeutics Corp. reported that it has demonstrated the ability to manufacture PsyBio-11040, one of its first promising therapeutic candidates...
October 7, 2021, 9:12 am